GHRH analogue peptide
Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone, abbreviated GHRH. In fundamental literature, the molecule is distinguished by its relationship to GHRH receptor interactions.
Receptor and signalling research
This 10 mg catalogue variant is suitable as a labelled reference item for controlled studies of peptide–receptor recognition, analytical comparison and cellular signalling pathways.
Scientific mechanism
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone, abbreviated GHRH. In fundamental receptor studies, the relevant molecular interaction is binding to the GHRH receptor, with cAMP-linked signalling in suitable cell models.
Batch documentation
Before each study, always check the product label, selected presentation and batch number. Compare these details, where available, with the batch documentation and lab results.
Important research-use notice
This item is intended exclusively for controlled analytical and in-vitro laboratory research. It is not intended for human or animal consumption, use, administration, diagnosis, prevention or treatment. VLT Labs does not provide dosage, medical, health or application advice.
